ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1826

Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity

Oshrat Tayer-Shifman1, Dorcas Beaton 2, Robin Green 3, Lesley Ruttan 3, Joan Wither 4, Maria Tartaglia 5, Mahta Kakvan 1, Sabrina Lombardi 3, Nicole Anderson 1, Jiandong Su 1, Dennisse Bonilla 1, Moe Zandy 1, May Choi 6, Marvin Fritzler 6 and Zahi Touma 7, 1University Health Network, University of Toronto, Toronto, ON, Canada, 2St. Michael's Hospital, Toronto, ON, Canada, 3University Health Network, Toronto, ON, Canada, 4University Health Network, Krembil Research Institute, Toronto, ON, Canada, 5University Health Network, University of Toronto, Toronto, ON, Canada, 6Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 7University Health Network, University of Toronto, Toronto, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: systemic lupus erythematosus (SLE) and cognitive dysfunction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 3S082: SLE – Clinical II: Flares & Morbidity of SLE (1824–1829)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Cognitive impairment (CI) is a common manifestation of systemic lupus erythematosus (SLE). The course of CI in SLE patients has been described as persistent in some patients and fluctuating in others. The objective was to describe the intra-individual course of CI over time, determine the severity of CI and the affected domains, over a 1-year period.

Methods: One-hundred and eleven consecutive SLE patients, aged 18-65 years, from a single centre (July 2016-March 2019) were included. Patients were administered the American College of Rheumatology (ACR) Neuropsychological Battery (NB) at baseline (T0), 6 months (T1) and 12 months (T2). Patients’ scores were compared to a normative data to obtain z-scores. CI was operationalized on the NB as a z-score of ≤-1.5 on ≥2 domains. Six domains were studied: simple attention and processing speed, visual-spatial construction, verbal fluency, learning and memory, executive functioning and manual motor speed and dexterity. Patients were defined as persistent CI if they had CI over 3 time-points (T0, T1 and T2), as stable non-CI if they did not have CI in any time-point, or as fluctuating CI if they had CI on 1-2 assessments. The severity of impairment of CI was determined based on the mean z-score of all 6 domains.

Results: : One-hundred and eleven patients (90% female) completed 3 assessments at T0, T1 and T2. The mean age was 43.6 ± 12 years and SLE duration at enrolment was 15.2 ± 11 years. Fifty-six percent (62/111) experienced CI at some point over one year. The prevalence of CI was 39.6%, 26.1% and 37.8% at T0, T1 and T2 respectively. Sixteen patients (14.4%) experienced persistent CI, 46 (41.4%) fluctuating CI and 49 patients (44.1%) were stable non-CI. Mean z-score of all 6 domains for each patient at each time point by the 3 groups (Fig. 1) showed almost complete separation of the groups, with the persistent CI patients displaying lower mean z-score than the fluctuating CI patients – implying more severe CI. Percentage of impairment of the 6 different domains in the 3 groups (Fig. 2) revealed the most affected domain over time was learning and memory followed by visual-spatial construction, simple attention and processing and motor speed and dexterity. Verbal fluency and executive functioning were not significantly affected. There was no marked change over time in the domains involvement of the persistent CI group. The most affected domains in the fluctuating CI group were similar and there was more variation in the degree of impairment of the involved domains over time.

Conclusion: Fifty-six percent (62/111) of patients experienced CI at some point over a one-year period. While CI fluctuated in 74% (46/62) of patients, 26% (16/62) experience persistent CI across all time points. Although the same domains were affected in fluctuating and persistent CI groups, fluctuating patients displayed less severe CI with more variation in the affected domains compared to persistent CI patients. Our results support the close monitoring of cognition in patients with SLE and further research into the causes and nature of CI in SLE patients.


Disclosure: O. Tayer-Shifman, None; D. Beaton, None; R. Green, None; L. Ruttan, None; J. Wither, None; M. Tartaglia, None; M. Kakvan, None; S. Lombardi, None; N. Anderson, None; J. Su, None; D. Bonilla, None; M. Zandy, None; M. Choi, None; M. Fritzler, Alexion Canada, 7, BioRad, 5, Dr. Fooke Laboratorien GmbH, 5, Euroimmun GmbH, 5, 7, ImmunoConcepts, 7, Inova Diagnostics, 5, 7, 8, Inova Diagnostics Inc. San diego, CA, 5, Inova Dx, Mikrogen GmbH, 5, Werfen International, 5; Z. Touma, None.

To cite this abstract in AMA style:

Tayer-Shifman O, Beaton D, Green R, Ruttan L, Wither J, Tartaglia M, Kakvan M, Lombardi S, Anderson N, Su J, Bonilla D, Zandy M, Choi M, Fritzler M, Touma Z. Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/describing-intra-individual-cognitive-function-course-over-time-in-lupus-patients-persistent-and-fluctuating-cognitive-impairment-affected-cognitive-domains-and-severity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/describing-intra-individual-cognitive-function-course-over-time-in-lupus-patients-persistent-and-fluctuating-cognitive-impairment-affected-cognitive-domains-and-severity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology